Raymond James lowers VersaBank stock price target to $13 from $15

Raymond James lowered its VersaBank (VBNK) price target to $13 from $15, maintaining an Outperform rating after fiscal Q2 results met expectations, while the stock fell 6.5% amid a cautious outlook and a relatively flat yield curve. Despite a 21 basis point NIM expansion in Q2, near-term NIM is expected to remain stable, and the bank reiterated its fiscal year-end growth targets, including $290 million in U.S. RPP and $1 billion CAD in CMHC-insured multifamily residential commitments. Other analysts have mixed views, with some downgrading the stock due to slower loan growth, while VersaBank progresses with strategic initiatives like divesting DRTC and launching DDRs.

Analysis

Raymond James recently adjusted its price target for VersaBank (NASDAQ: VBNK) downwards to $13 from $15, though it maintained an Outperform rating subsequent to the bank's fiscal second-quarter 2025 results, which were in line with market expectations. Despite this, VersaBank's shares experienced a significant 6.5% decline on the day of the announcement, underperforming the KBW Regional Banking Index's 1.2% fall, largely attributed to a cautious outlook stemming from a relatively flat yield curve. This flat yield curve is anticipated to keep net interest margins (NIM) stable in the near term, even after a 21 basis point expansion in Q2. The stock currently trades at a P/E ratio of 14.5x with a market capitalization of $351 million and has seen a 21.7% year-to-date decline, with two analysts recently revising earnings expectations downward. Nevertheless, Raymond James remains optimistic about VersaBank's long-term prospects, as the bank reaffirmed its fiscal year-end growth targets, including $290 million in its U.S. residential property portfolio (RPP) and $1 billion CAD in Canada Mortgage and Housing Corporation (CMHC)-insured multifamily residential commitments. The bank's Canadian insolvency business is performing as expected, contributing to anticipated growth in low-cost deposits. Strategic initiatives such as the planned divestment of Digital Resource Technology Corporation (DRTC) and the upcoming launch of digital deposit receipts (DDRs) are progressing, though not yet factored into Raymond James' financial model. Other analysts present a mixed view: Keefe, Bruyette & Woods lowered their target to $22 from $27 but maintained Outperform, citing slower U.S. Point of Sale growth but recognizing long-term potential, while Roth/MKM downgraded VBNK to Neutral with a $10.40 target due to slow loan growth and delays in the U.S. Recurring Payment Program. VersaBank's Q1 FY25 results showed a 9.1% loan growth, its lowest since early 2021, linked to weak Canadian economic fundamentals. The bank is also marketing its DTR Cyber subsidiary for sale and sees potential in its new Digital Meteor segment focusing on DDRs, while its move to a U.S. headquarters aims to reduce regulatory costs and broaden its investor base. The operational start of VersaBank’s first U.S. RPP partner was later than expected, impacting current loan balances. Overall, the situation reflects a company navigating near-term headwinds, evidenced by a 'mixed' general sentiment score of -0.05 and a negative per-ticker sentiment for VBNK (-0.5), while pursuing strategic shifts that could offer future growth.

Key Decisions for Investors

• Investors should closely monitor VersaBank's net interest margin trajectory in the context of the flat yield curve and its potential impact on near-term earnings, despite the recent quarterly expansion and management's reiterated growth targets.
• The successful and timely execution of key strategic initiatives, including the DRTC divestment, the market introduction of digital deposit receipts, and the scaling of the U.S. residential property portfolio against its $290 million target, are critical catalysts to watch.
• Given the divergent analyst opinions, recent downward earnings revisions, and significant stock underperformance year-to-date, investors should weigh the bank's long-term organic growth potential and strategic initiatives against prevailing macroeconomic headwinds in Canada, execution risks in its U.S. expansion, and the specific concerns raised about loan growth rates.